Evidence map›Paper›PMID 42806849›Full record

ArticleJournal of Zhejiang University. Science. B2026

Cognitive function among COVID-19 survivors in the subacute phase during the epidemic of Omicron variant in China.

Xue Luo, Shufei Zeng, Shuai Liu, Yuanhui Li, Leqin Fang, Dai Li, Qianqian Xin, Shixu DU, Yan Xu, Bin Zhang

Abstract read
In one paragraph

Article in Journal of Zhejiang University. Science. B, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Digital mental health: innovations in assessment and intervention.Journal of Zhejiang University. Science. B · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xue LuoDepartment of Psychiatry, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Shufei ZengDepartment of Psychiatry, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Shuai LiuDepartment of Psychiatry, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Yuanhui LiAdai Technology (Beijing) Company Limited, Beijing 100123, China.
Leqin FangDepartment of Psychiatry, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Dai LiAdai Technology (Beijing) Company Limited, Beijing 100123, China.
Qianqian XinDepartment of Psychiatry, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Shixu DUDepartment of Psychiatry, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Yan XuDepartment of Psychiatry, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Bin ZhangDepartment of Psychiatry, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. zhang73bin@hotmail.com.

Funding

the Clinical Research Project of Nanfang Hospital, Southern Medical University 2021CR009the Guangdong Basic and Applied Basic Research Foundation 2023A1515010456the National Key R&D Program of China 2021YFC2501500the National Natural Science Foundation of China 82271525the Science and Technology Planning Project of Guangdong Province 207157464043
6 · The paper itself

Abstract

Following the relaxation of pandemic control measures in China, the impact of coronavirus disease 2019 (COVID-19) on cognitive function in the Chinese population has not been investigated. Therefore, this study aimed to assess cognitive function and identify its risk factors in the subacute phase (<3 months) of COVID-19 patients during the epidemic wave of the Omicron variant. In this nationwide smartphone-based online assessment from January 15 to 29, 2023, the Integrated Cognitive Assessment (ICA) and the Number Ordering Test (NOT) were used to assess cognitive function. Among the 9663 participants, 8905 (92.2%) were COVID-19 survivors. These patients performed poorly on most neuropsychological results (

Indexed as

CognitionCOVID-19SurvivorsAdultAgedChinaFemaleHumansMaleMiddle AgedNeuropsychological TestsPandemicsPost-Acute COVID-19 SyndromeRisk FactorsSARS-CoV-2Cognitive functionCoronavirus disease 2019 (COVID-19)Omicron variantRisk factorSubacute phase

Identifiers

PMID42806849
PMCPMC13621208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.